AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
39.86
+0.61 (1.55%)
Dec 5, 2025, 4:00 PM EST - Market closed
AtriCure Employees
AtriCure had 1,300 employees as of December 31, 2024. The number of employees increased by 100 or 8.33% compared to the previous year.
Employees
1,300
Change (1Y)
100
Growth (1Y)
8.33%
Revenue / Employee
$398,696
Profits / Employee
-$22,132
Market Cap
1.98B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ATRC News
- 6 days ago - Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - The Motley Fool
- 17 days ago - AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 25 days ago - AtriCure, Inc. (ATRC) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - AtriCure, Inc. (ATRC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025 - Business Wire
- 5 weeks ago - AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial - Business Wire
- 5 weeks ago - AtriCure to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - AtriCure to Announce Third Quarter 2025 Financial Results - Business Wire